Hsu KC - Search Results

1

From Sea to Science: Coral Aquaculture for Sustainable Anticancer Drug Development.

Lin HY, Tsai TN, Hsu KC, Hsu YM, Chiang LC, El-Shazly M, Chang KM, Lin YH, Tu SY, Lin TE, Du YC, Liu YC, Lu MC. Lin HY, et al. Among authors: hsu ym, hsu kc. Mar Drugs. 2024 Jul 19;22(7):323. doi: 10.3390/md22070323. Mar Drugs. 2024. PMID: 39057432 Free PMC article.

2

Novel Class IIa-Selective Histone Deacetylase Inhibitors Discovered Using an in Silico Virtual Screening Approach.

Hsu KC, Liu CY, Lin TE, Hsieh JH, Sung TY, Tseng HJ, Yang JM, Huang WJ. Hsu KC, et al. Sci Rep. 2017 Jun 12;7(1):3228. doi: 10.1038/s41598-017-03417-1. Sci Rep. 2017. PMID: 28607401 Free PMC article.

3

Structural Insights into the Cytotoxic Mechanism of Vibrio parahaemolyticus PirA^vp and PirB^vp Toxins.

Lin SJ, Hsu KC, Wang HC. Lin SJ, et al. Among authors: hsu kc. Mar Drugs. 2017 Dec 1;15(12):373. doi: 10.3390/md15120373. Mar Drugs. 2017. PMID: 29194352 Free PMC article. Review.

4

Discovery of aliphatic-chain hydroxamates containing indole derivatives with potent class I histone deacetylase inhibitory activities.

Chao SW, Chen LC, Yu CC, Liu CY, Lin TE, Guh JH, Wang CY, Chen CY, Hsu KC, Huang WJ. Chao SW, et al. Among authors: hsu kc. Eur J Med Chem. 2018 Jan 1;143:792-805. doi: 10.1016/j.ejmech.2017.11.092. Epub 2017 Dec 5. Eur J Med Chem. 2018. PMID: 29223096

5

A Novel Dual HDAC6 and Tubulin Inhibitor, MPT0B451, Displays Anti-tumor Ability in Human Cancer Cells in Vitro and in Vivo.

Wu YW, Hsu KC, Lee HY, Huang TC, Lin TE, Chen YL, Sung TY, Liou JP, Hwang-Verslues WW, Pan SL, HuangFu WC. Wu YW, et al. Among authors: hsu kc. Front Pharmacol. 2018 Mar 13;9:205. doi: 10.3389/fphar.2018.00205. eCollection 2018. Front Pharmacol. 2018. PMID: 29593536 Free PMC article.

6

Design of Diarylheptanoid Derivatives as Dual Inhibitors Against Class IIa Histone Deacetylase and β-amyloid Aggregation.

Chen LC, Tseng HJ, Liu CY, Huang YY, Yen CC, Weng JR, Lu YL, Hou WC, Lin TE, Pan IH, Huang KK, Huang WJ, Hsu KC. Chen LC, et al. Among authors: hsu kc. Front Pharmacol. 2018 Jul 3;9:708. doi: 10.3389/fphar.2018.00708. eCollection 2018. Front Pharmacol. 2018. PMID: 30018556 Free PMC article.

7

5-Aroylindoles Act as Selective Histone Deacetylase 6 Inhibitors Ameliorating Alzheimer's Disease Phenotypes.

Lee HY, Fan SJ, Huang FI, Chao HY, Hsu KC, Lin TE, Yeh TK, Lai MJ, Li YH, Huang HL, Yang CR, Liou JP. Lee HY, et al. Among authors: hsu kc. J Med Chem. 2018 Aug 23;61(16):7087-7102. doi: 10.1021/acs.jmedchem.8b00151. Epub 2018 Aug 9. J Med Chem. 2018. PMID: 30028616

8

1-Arylsulfonyl indoline-benzamides as a new antitubulin agents, with inhibition of histone deacetylase.

Lai MJ, Ojha R, Lin MH, Liu YM, Lee HY, Lin TE, Hsu KC, Chang CY, Chen MC, Nepali K, Chang JY, Liou JP. Lai MJ, et al. Among authors: hsu kc. Eur J Med Chem. 2019 Jan 15;162:612-630. doi: 10.1016/j.ejmech.2018.10.066. Epub 2018 Nov 3. Eur J Med Chem. 2019. PMID: 30476825

9

A Novel Selective JAK2 Inhibitor Identified Using Pharmacological Interactions.

Lin TE, HuangFu WC, Chao MW, Sung TY, Chang CD, Chen YY, Hsieh JH, Tu HJ, Huang HL, Pan SL, Hsu KC. Lin TE, et al. Among authors: hsu kc. Front Pharmacol. 2018 Dec 4;9:1379. doi: 10.3389/fphar.2018.01379. eCollection 2018. Front Pharmacol. 2018. PMID: 30564118 Free PMC article.

10

The role of ubiquitin-specific peptidases in cancer progression.

Young MJ, Hsu KC, Lin TE, Chang WC, Hung JJ. Young MJ, et al. Among authors: hsu kc. J Biomed Sci. 2019 May 27;26(1):42. doi: 10.1186/s12929-019-0522-0. J Biomed Sci. 2019. PMID: 31133011 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

553 results

Search Page

Filters